Please assess the completion status of the following clinical trial:

Trial Title: Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Neurological death donors in whom brain death determination is imminent~* First person or next of kin consent for research becomes available~* High risk donor, as defined by the following criteria i) Known liver disease ii) Hepatitis BsAg, BcAb, B DNA, Hepatitis C Ab or Hepatitis C RNA positivity iii) Age \>= 50 iv) Any of the following risk factors for fatty liver disease a) BMI \>= 30 b) History of Type 2 Diabetes Mellitus c) Ultrasound, Computerized Tomography or other imaging modalities suggesting steatosis v) Any of the following risk factors for chronic liver disease~  1. Greater than 2 drinks of alcohol daily currently or in their history~ 2. Current IV drug use~ 3. Ultrasound, Computerized Tomography or other imaging modalities suggesting cirrhosis~Exclusion Criteria:~* Donation after cardiac death donors~* Live organ donors~* No first person consent and next of kin decline research consent~* Donors in whom it has been established the liver will not be shared~* Donors in whom percutaneous liver biopsy has been performed within the past month for any indication and the biopsy results are available and considered reliable.~* Donor with a contraindication to liver biopsy, including INR \> 2, PTT \> 75, Platelets \< 70,000, history of coagulopathy, current or recent use (within 7 days) of antiplatelet agent such as aspirin or Plavix, and hemodynamic instability defined as a MAP less than 65mmHg.~* Inability to position donor appropriately for performance of PPB~* Unavailability of pathology staff to analyze specimen in a timely manner

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): In this group a liver biopsy will not be performed. All management would be as per standard of practice
- Percutaneous liver biopsy (Type: ACTIVE_COMPARATOR): In this group a percutaneous biopsy of the liver will be performed prior to organ recovery

Based on this trial design, predict the completion outcome and termination type (if applicable).